Self-regulating nanoparticles kill cancerous cells without damaging healthy tissue

The difficulty of improving the treatment of Alzheimer’s disease has become clear

Countries have pushed pharmaceutical production to the top of their agenda

Unapproved antibiotics are rife in India, undermining efforts to tackle resistance

Gene editing tool CRISPR/Cas9 has electrified the biotech industry

Is the UK medical board responsible for approving new drugs outdated?

Will rapid reform open the world’s second biggest drug market?

How close are we to a drug-based solution to opioid addiction?

Novartis has launched a programme to add novel treatments to its malaria pipeline

How can big pharma restore its credibility in the eyes of patients and policymakers?

Has Amazon's acquisition of PillPack changed the retail drugstore forever?

Is the microbiome as important for precision medicine as genetics?

Tracking a decade of progress in preventative HPV vaccines